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1. Introduction
Pulmonary function testing is used to categorise the nature, severity 
and progression of respiratory disorders and to measure the patient’s 
response to therapy. Office spirometry remains an integral part of a 
comprehensive respiratory evaluation and is often used as an adjunct 
to the diagnosis of asthma and chronic obstructive pulmonary disease 
(COPD) and to screen for occupational lung diseases.1,2 However, 
improper standards and operating procedures significantly reduce its 
value in the diagnosis of and screening for these conditions.1,2 
Adequate spirometry relies on a competent operator, accurate 
equipment, standardised operating procedures (SOPs), quality 
control and patient co-operation.2,3 Moreover, appropriate and 
validated reference standards must be used.2,3 Spirometry should 
always be viewed within the clinical context, and not as a stand-alone 
investigation.3 
The most recent South African guideline for office spirometry 
in 20042 has been superseded by comprehensive international 
guidelines.3-6 Furthermore, there is a growing body of evidence 
regarding local reference standards.7-11 This article aims to provide an 
updated and simplified guideline for the use of office spirometry at 
the primary healthcare level. 
2. Basic equipment and definitions
2.1 Spirometry 
Spirometry involves the measurement of the air volumes and airflow 
rates of the lung. These are dependent on the physical properties of 
the airways, lung parenchyma, pleura and chest wall and the strength 
of respiratory muscles.1,2 Practically all modern commercially 
available computerised spirometers are flow-type spirometers that 
use a flow-sensor (pneumotach) to derive volumes.2 They can display 
expiratory and inspiratory manoeuvres in real time as flow-volume 
loops, allowing instant pattern recognition. 
Standard features of modern spirometers include software for 
the storage of large data sets and the ability to express measured 
values as percentage predicted, using various reference value sets 
as a guide. These spirometers generally require greater expertise 
to operate, calibrate and maintain than the older volume-type 
spirometers, which measured volume directly and produced 
volume-time curves. 
Spirograms (Fig. 1) are graphic displays produced by spirometers, 
and include volume-time curves (from both types of spirometers) 
and flow-volume curves (from newer flow-type spirometers). 
Modern equipment also automatically superimposes measured 
spirograms onto predicted curves. 
2.2 Measurements
The minimum measurements that basic office spirometers should 
produce include: 
• Forced vital capacity (FVC): The maximum volume of gas 
exhaled from the position of maximal inspiration by means of 
a rapid, maximally forced expiratory effort, expressed in litres 
(body temperature and ambient pressure, saturated with water 
vapour) (BTPS). BTPS refers to a standardised volume at normal 
body temperature (37°C) at ambient pressure, saturated with 
water vapour.
• Forced expiratory volume (FEV)1: The volume of gas exhaled 
during the first second of the FVC manoeuvre, expressed in 
litres (BTPS).
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• FEV1/FVC%: The observed FEV1 expressed as the percentage of 
observed FVC (FEV1/FVC × 100).
• Peak expiratory flow (PEF): The maximum flow generated 
with an FVC manoeuvre, usually expressed in litres per 
second (BTPS).
Additional measurements may include: 
• Vital capacity (VC): The ‘slow’ VC (sometimes referred 
to as SVC) is the total volume of gas inhaled from the 
position of maximal expiration or exhaled from the position 
of maximal inspiration. It is measured with a relaxed/
slow breathing manoeuvre either during inspiration or 
expiration. VC is expressed in litres (BTPS), and may be 
useful for demonstrating small airway collapse in COPD 
patients. 
• FEVX: The volume of gas exhaled during the first X seconds of 
the FVC manoeuvre, expressed in litres (BTPS), e.g. FEV6.
• FEFX%: The instantaneous forced expiratory flow rate at the 
point where X% of the FVC has been expired, e.g. at 25%, 50% 
and 75% (FEF25%, FEF50% and FEF75%). These measurements are 
expressed in litres per second (BTPS).
• FEF25-75%: Average flow during the middle 50% of an FVC 
manoeuvre, also sometimes referred to as the maximum mid-
expiratory flow. Expressed in litres per second (BTPS).
2.3 Accuracy, repeatability and reproducibility
Accuracy is the truthfulness or closeness of agreement between the 
result of a measurement and the true value.3 
Repeatability is the closeness of agreement (precision) between 
the results of successive measurements of the same patient (provided 
that the same methods, instrument, observer and conditions are 
present for thesem measurements). 
Reproducibility is the closeness of agreement of the results of 
successive measurements of the same item where the measurements 
are carried out with changed conditions (e.g. methods, observer, 
instrument, location, conditions of use, or time).3 
2.4 Measurement range and equipment resolution 
The measurement range is the range over which the manufacturer 
indicates that the device complies with the equipment resolution, 
which is the smallest detectable change in measurement.3
2.5 Calibration and validation 
Calibration is the process whereby a device’s accuracy and 
repeatability are tested and corrected using a gold standard, e.g. a 
calibration syringe with standard volumes. Validation is the process 
of establishing and certifying that the device is correctly calibrated. 
3. Indications for spirometry 
The indications for spirometry in a particular patient should be 
unambiguous and should be documented in each case. Indications 
include:2,4 
• Diagnostic 
• evaluating abnormal respiratory symptoms and signs (in 
individuals with suspected obstructive and/or restrictive lung 
diseases) 
• measuring the extent to which a disease affects the respiratory 
system
• screening individuals at risk, e.g. smokers, employees exposed 
to substances known to cause respiratory disease
• preoperative risk assessment 
• assessing prognosis
• Monitoring 
• assessing interventions/treatment action plan
• monitoring the course of chronic lung diseases
• monitoring patients exposed to injurious agents 
• screening for pulmonary toxicity secondary to drugs
• Evaluation of impairment 
• insurance and disability 
• rehabilitation
• medico-legal cases 
• Public health 
• epidemiological surveys and derivation of reference equations. 
4. Specifications and technical 
preparation for spirometry
4.1 Validation 
All equipment should have proof of validation.2,4 Accuracy depends 
on the system’s resolution (minimum detectable volume or flow) 
and linearity (consistency), from the measuring components to the 
display and graphical output. 
The European Respiratory Society/American Thoracic Society 
(ERS/ATS) Taskforce for the Standardisation of Lung Function Testing 
has recommended minimum performance criteria for spirometers, 
and guidelines for validating equipment using waveform-generated 
calibration syringes5 (Tables 1 and 2). Other recommendations include: 
Fig. 1. A: volume-time, and B: flow-volume curves. In the flow-type spirometer, 
FEV1 is a derived value. It can only be read from the flow-volume graph if a 
1-second timer is displayed. Figure adapted from Van Schalkwyk et al.2 
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• a BTPS-correction facility. The volume of exhaled gas is 
measured outside the body at ambient conditions, designated 
ambient temperature and pressure, saturated with water vapour 
(ATPS). This facility corrects these measurements to reflect 
conditions inside the lung (BTPS). Without it, volumes have 
to be corrected manually. Depending on the environmental 
temperature, the BTPS correction factor may be as large as 10%. 
Ambient temperature, barometric pressure and time of day 
should therefore be recorded. 
• the facility to generate real-time spirograms, in order to enhance 
feedback and subject compliance
• stating the source(s) of reference values, combined with the 
facility to select or enter appropriate values manually
• computer-driven technical quality indicators that meet ERS/
ATS standards 
• printing or electronic facility for record-keeping purposes
• adequate ability to save large numbers of tests and test quality 
indicators where needed, e.g. for occupational surveillance.
4.2 Calibration and equipment quality control 
To ensure that they remain accurate during use, all diagnostic 
spirometers must be volume-calibrated at least daily, using a calibrated 
syringe with a volume of at least 3 l. In some settings (e.g. industrial 
surveys), the calibration should be performed twice daily. Moreover, 
calibration should be repeated if the temperature changes markedly 
over the course of a day.
Flow-type spirometers should be calibrated with at least 3 
discharges to give a range of flows from 0.5 l/s to 12 l /s (with the 
3 l syringe this equates to times of approximately 6 s and <0.5 s). 
This must be done with the machine switched to calibration mode, 
to prevent BTPS-correction because room air has been injected. 
Also enter ambient temperature and barometric pressure readings, 
which may be obtained from the local airport or weather bureau. 
Calibration is complete when the recorded volumes are within 3.5% 
for each flow rate tested. Calibration should be performed with 
in-line filters installed. 
For linearity, a volume calibration check should be performed 
weekly, using a 3 l syringe to deliver 3 constant flows at a low flow, 
followed by 3 at a mid-range flow and finally 3 at a high flow. The 
volumes achieved at each of these flows should meet the accuracy 
requirement of +/- 3.5%.4 
Volume-type spirometers must be evaluated for leaks daily (with 
0.3 kPa constant pressure for 1 minute), and for volume linearity 
quarterly (1l increments with a calibrating syringe measured over the 
entire volume range).4 
Further measures for equipment quality control are the installation 
of software updates (which should be logged), and quarterly calibration 
of the time clock (by mechanical recorded checks with a stopwatch). 
In addition to calibration, spirometers must be maintained according 
to the manufacturer’s specifications. For example, pneumotachs must 
be cleaned weekly (more frequently if there is visible condensation) 
as they are particularly sensitive to moisture and secretions. It is 
advisable that the local supplier/manufacturer should also service 
spirometers annually. 
At a minimum, a calibration and maintenance log and electronic 
or hard copies of whole spirograms must be kept, so that the accuracy 
and precision of past tests can be verified. Additionally, SOPs should 
be documented and kept for reference.
4.3 Ambient conditions 
Ambient temperature, barometric pressure and time of day 
should be recorded daily. Temperature is a significant variable in 
spirometry, and may be measured directly by a simple thermometer 
or internal thermostat (i.e. directly by the equipment). It is 
the responsibility of the operator to confirm the accuracy of 
temperature measurements, and the manufacturer’s responsibility 














FVC 0.5 - 8.0 +/- 3% of reading or 
+/- 0.050 l, whichever is 
greater 
+/- 4.5% of reading or +/- 0.200 l, 
whichever is greater
0 - 14 30 24 ATS waveforms, 
3l calibration 
syringe 
FEV1 0.5 - 8.0 +/- 3% of reading or 
+/- 0.050 l, whichever is 
greater
+/- 4.5% of reading or +/- 0.200 l, 
whichever is greater
0 - 14 1 24 ATS waveforms
PEF NA +/- 10% of reading or +/- 
0.30 l/s, whichever is
greater 
+/- 5% of reading or 0.15 l/s, 
whichever is greater
0 - 14      24 ATS flow 
waveforms
*Percentage deviation = 100 x (average-standard)/standard.
†Percentage span = 100 (maximum-minimum)/average. 
Table 2. Minimum scale for spirograms*
Parameter 
Instrument display Graphical output 
Required resolution Scaling Required resolution Scaling 
Volume 0.050 l 5 mm/l 0.025 l 10 mm/l
Flow 0.200 l/s 2.5 mm/l/s 0.100 l/s 5 mm/l/s
Time 0.2 s 10 mm/s 0.2 s 20 mm/s
*The correct aspect ratio for a flow v. volume display is two units of flow per one unit of volume.
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to describe or provide a clear mechanism for checking the accuracy 
of instrument measurements.3 
5. Hygiene and infection control
5.1 Rationale
There is a small but real risk of transmitting infections to test subjects 
and staff during pulmonary function testing.2,3 Practically all the 
components of the spirometry system have been implicated, and 
transmission can occur through direct and indirect contact. Upper 
respiratory diseases, enteric infections and blood-borne infections 
can be transmitted through direct contact. Hepatitis and HIV 
transmission becomes possibile if patients suffer from open oral 
mucosal ulcers or possible bleeding gums.2,3 
Tuberculosis and various viral and bacterial infections can potentially 
be transmitted via indirect contact through aerosol droplets. Mouthpieces 
and the immediately proximal surfaces of valves or tubing are the most 
likely sources of contamination in the last two instances. The type of 
test manoeuvre used (and specifically whether the patient inhales from 
the spirometer) significantly influences the extent of infection control 
needed. Using an expiratory manoeuvre only, without inhalation from 
the spirometer, reduces the potential for cross-contamination and is the 
method of choice for mass screening purposes.2
5.2 Infection control recommendations 
Transmission to operators can be prevented by proper hand-
washing and using barrier devices, e.g. gloves.3 Hands should be 
washed following direct handling of mouthpieces, tubing, valves or 
interior spirometer surfaces and always between patients. Operators 
who have open cuts or lesions on their hands should wear gloves, 
particularly when handling contaminated equipment. 
Cross-contamination should be avoided. Mouthpieces, nose clips 
and any other equipment that comes into direct contact with mucosal 
surfaces should be disinfected, sterilised or discarded (if disposable) 
after each use.2 Any equipment surface (tubing, valves or manifolds) 
showing condensation from expired air should be disinfected or 
sterilised before re-use. Manufacturers’ recommendations should be 
adhered to, particularly regarding the choice of sterilising agents, as 
some equipment may be damaged by chemicals or heat. 
Between subjects, volume-based spirometers used with a closed-
circuit technique should be flushed with room air at least 5 times 
over the spirometer’s entire volume range to ensure clearance of 
droplet nuclei. The breathing tube and mouthpiece should be 
decontaminated or changed between patients.3 
When an open circuit (either volume or flow spirometers) is 
used, only the portion of the circuit through which rebreathing 
occurs must be decontaminated between patients, as long as the 
subject only exhales into the spirometer.2,3 
With inhalation, however, additional measures must be put in 
place: after each subject either in-line disposable filters must be 
used and replaced, or the involved parts of the system (spirometer, 
breathing tubes and resistive element of the pneumotach) must 
be decontaminated/sterilised/flushed. Most units employ in-line 
filters, as re-calibration is necessary every time a system has been 
dismantled for decontamination.
Special precautions must be taken for patients with known 
transmissible infections such as tuberculosis, or those with current 
haemoptysis. In-line filters should be used routinely (even if expiratory 
manoeuvres are performed exclusively), and after each use contaminated 
surfaces should be sterilised and equipment decontaminated. Proper 
attention should also be paid to environmental control, e.g. ventilation. 
Practical considerations include testing such cases at the end of the day 
(to allow overnight decontamination of equipment). 
6. Patient considerations and 
preparation
The patient’s gender, age, race, standing height and weight must be 
recorded on the day of the test, as these variables (particularly gender, 
race and height) are required for reference purposes. Height (and weight) 
should be measured with the subject barefoot (feet together), wearing 
only light clothing and looking straight ahead. The body mass index (kg/
m2) should be calculated. Smoking status and the use of any medication 
that can influence spirometry should be documented, including the type 
and dose of drugs and when they were last administered. 
6.1 Contraindications
There are few absolute contraindications for spirometry. A major 
exclusion criterion in routine practice is current respiratory 
infections in individuals participating in impairment/disability 
assessment, as respiratory infections can temporarily impair lung 
function.2 The current ATS/ERS guideline also recommends that 
lung function testing should not be performed within one month of a 
myocardial infarction.3 Situations where suboptimal testing is likely 
include chest and abdominal pain, facial discomfort exacerbated by 
a mouthpiece, stress incontinence, dementia or an acute confusional 
state.3 Patients with severe emphysema who experience syncope with 
forced and prolonged expiration should not be retested.
6.2 Subject preparation 
Patients should abstain from smoking (within 1 hour) and consuming 
alcohol (within 4 hours) of testing, and should not perform any 
vigorous exercise 30 minutes before testing. Clothing that restricts 
chest and abdominal movement and a large meal within 2 hours of 
testing should also be avoided. Patients should be informed of these 
requirements prior to testing, and deviations should be documented.
Subjects should be relaxed and comfortable before and during 
testing. Tight-fitting clothing should be loosened and distractions 
minimised. Well-fitting dentures can be left in place but loose-
fitting ones are best removed. The use of a nose clip is strongly 
recommended. 
It is imperative to use simple instructions to ensure optimum 
co-operation, which may include real-time visual aids. Patients should 
be given feedback regarding their performance and continuously 
encouraged (including descriptions of potential improvements that 
can be made). 
6.3 Subject positioning 
Spirometry may be performed either sitting or standing (the position 
should be reported).12,13 The sitting position is the most widely used, 
mainly because of the risk of syncope during forced expiration. The 
chair should have arm rests, but no wheels. Patients with central 
obesity may achieve deeper inspiration while standing, and thus have 
higher volumes and flows when tested in this position.3 
7. Execution of tests
7.1 FVC and FEV1 test manoeuvres
The operator should follow the summarised procedures (Table 
3). The performance of an FVC manoeuvre has 3 distinct phases: 
(i) maximal inspiration; (ii) rapid, forceful exhalation (a ‘blast’); and 
(iii) continued complete exhalation to the end of test (EOT).4 There 
are essentially two accepted procedures: 
• Closed circuit method. This allows the recording of 
inspiration and expiration, and generation of flow-volume 
loops (on a flow-type spirometer). The subject assumes the 
correct posture, a nose clip is attached, and a mouthpiece is 
inserted around which the subject closes their lips. The subject 
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is instructed to inhale completely and rapidly with a pause of 
<1 s at total lung capacity (TLC), followed by rapid, forceful 
and maximal exhalation until no further air can be expelled 
(maintaining an upright posture). 
• Open circuit (expiration-only) method. This is often employed 
for mass screening, and consists of an FVC test with or without 
a slow VC test. After the subject assumes the correct posture, a 
clip is attached to their nose. The subject is required to inhale 
completely and rapidly with a pause of <1 s at TLC. Thereafter 
a mouthpiece is inserted and the lips must be closed around it. 
Expiration must be rapid, forceful and complete, lasting at least 6 
s. A slow VC test is sometimes performed, as a reduction in the 
FVC compared with the slow VC suggests dynamic collapse of 
airways during forced expiration. The slow VC test is preceded by 
a maximal inspiration, the mouthpiece is inserted and the patient 
then breathes out in a relaxed fashion and for as long as possible.2 
7.2 Quality assurance
Many within-manoeuvre and between-manoeuvre criteria must be 
satisfied to ensure adequate quality:
• Start and end of test. The start of test (‘time zero’) should be 
determined by the back-extrapolation method (Fig. 2), and defines 
the start for all timed measurements.4,14 The steepest slope on the 
volume-time curve is used for manual measurements, whereas the 
largest slope averaged over an 80 ms period is used for computerised 
back-extrapolation.4,15 Current recommended EOT criteria include: 
(i) subjects cannot or should not continue further exhalation (due 
to discomfort or the risk of syncope); or (ii) the volume time curve 
shows no change in volume (<0.025 l for ≥1 s); or (iii) the subject 
has attempted to exhale ≥6 s (≥3 s for children <10 years).4,5 
• Acceptability criteria. Table 4 summarises the within-manoeuvre 
acceptability criteria for the recording of FVC and FEV1. 
Acceptable curves must satisfy all 7 criteria listed, whereas ‘usable’ 
curves only need a good start (without hesitation) and for the 
subject to be free of coughing during the first second (Figs 3 - 5). 
• Repeatability. An adequate test requires a minimum of 3 
acceptable FVC manoeuvres. Acceptable repeatability is achieved 
when the difference between the largest and the next largest FVC 
and FEV1 is ≤0.150 l (Fig. 6).
4,16 For patients with a VC of 1.0 l, 
this value is 0.100 l. If these criteria are not met after 3 attempts, 
additional testing should be performed, up to a maximum of 8 
manoeuvres, or until the subject cannot or should not continue, 
or it is obvious that perseverance will not change the outcome.4 
When repeatability is not achieved, results are labelled as such.
7.3 Test result selection 
The FVC and FEV1 should be measured from a series of at least 3 
acceptable forced expiratory curves. The largest FVC and the largest 
FEV1 (BTPS) should be recorded and used to determine other 
indices, even if they do not come from the same attempt. 
7.4 Other derived indices 
The PEF is obtained from flow-volume curve data, and should 
be reported. It is the maximum expiratory flow achieved from a 
maximum forced expiration, starting without hesitation from the 
point of maximal lung inflation, expressed in l/s.4 PEF should be 
achieved within the first 25% of the volume expired from maximum 
inspiration (most subjects can produce PEF within the first 15% of 
the volume expired.)
The FEF25-75% is also known as the maximum mid-expiratory flow, 
and has to be measured with an accuracy of at least +/- 5% of the 
reading or +/- 0.200 l/s, whichever is less, over a range of up to 7 
l/s.4 It is dependent on the validity of the FVC measurement and the 
degree of expiratory effort.4
7.5 Flow volume loops
In most laboratories, flow volume loops are generated in real-time during 
FVC and FEV1 test manoeuvres. There are two acceptable approaches: 
• The subject performs tidal breathing at FRC, and then, in one 
continuous sequence, performs a slow expiration to residual 
volume, followed immediately by a slow inspiration to TLC, 
and a rapid full expiration with maximal effort to RV (during 
which time FVC and FEV1 are measured). This is immediately 
followed by a rapid full inspiration with maximum effort back 
to TLC.4 Both VC as well as FVC can be measured with this 
technique.
Table 3. Procedures for recording FVC*
Verify spirometer calibration 
Explain the procedure
Subject preparation Enquire about medication use and 
smoking status 
Measure weight and height 
Infection control Wash hands
Disposable filter
Instruct and demonstrate test Correct positioning and posture
Complete and rapid inhalation 
Forced, maximal exhalation 
Perform manoeuvre Closed v. open circuit (see text)
Repeat instructions as necessary
Repeat for a minimum of 3 tests 
Verify test quality Acceptability 
Reproducibility 
Perform more attempts Maximum of 8 
*Adapted from Miller et al.4
Fig. 2. Expanded version of the early part of a subject’s volume-time 
spirogram, illustrating back-extrapolation through the steepest part of the 
curve, where flow is peak expiratory flow (PEF), to determine the new ‘time 
zero’. Forced vital capacity (FVC) = 4.255 l, back-extrapolated volume (EV) 
= 0.128 l (3.0% FVC). ---- = back-extrapolation line through PEF. Figure 
adapted from Miller et al.4
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• The subject takes a rapid full inspiration to TLC from room 
air through the mouth, thereafter a mouthpiece is inserted and 
then, without hesitation, an expiration with maximum force is 
performed until no more air can be expelled, followed by rapid 
maximum inspiration.4
The principles for within- and between-manoeuvre evaluation are 
the same as for FVC. 
7.6 Reversibility testing 
The purpose of a bronchodilator test is to determine whether airway 
obstruction, as measured by spirometry, is reversible with an inhaled 
bronchodilator (the choice of drug, dose and delivery mode is a 
Table 4. Within-manoeuvre acceptability criteria for the 
recording of FVC and FEV1
*
No artefacts Coughing during first second of expiration 
Glottis closure (Valsalva manoeuvre) or hesitation
Early termination or submaximal effort 
Leakage
Obstructed mouthpiece 
Good starts Extrapolated volume <5% of FVC or 0.150 l 
(whichever is greater) 
Exhalation At least 6 s (less only if the subject cannot or should 
not continue) 
*Adapted from Miller et al.4
Fig. 3. Flow-volume curve exhibiting a cough artefact (X) that can influence 
observed forced vital capacity and FEV1. Volume-time graphs are better for 
evaluating end-of-test quality.
Fig. 4. Flow-volume curve exhibiting glottis closure (X) resulting in 
premature termination of effort and reduced observed forced vital capacity.
Fig. 5. Flow-volume curve with a late peak. Failure to demonstrate 
reproducibility will confirm these as submaximal efforts.
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clinical decision).2,4 A standard bronchodilator test is performed as 
follows: 
• The patient should abstain from using short-acting inhaled drugs 
at least 4 hours before testing. Long-acting bronchodilators and 
oral therapy with aminophylline should be stopped for 12 hours 
before the test. No smoking is allowed from one hour before 
testing and throughout the test procedure.
• Three acceptable tests of FEV1, FVC and PEF (of which 2 are 
repeatable) should be performed. 
• A short-acting bronchodilator is administered. After a gentle 
expiration to FRC, a dose of 100 µg of salbutamol (or 
equivalent) is inhaled in one breath to TLC. The breath is then 
held for 10 s before exhaling. Four separate doses (total dose 
400 µg) are delivered at 30 s intervals. Ipratropium bromide 
(total dose 4 x 40 = 160 µg) can be used as an alternative.
• A waiting period of 10 - 15 minutes follows (30 minutes for 
ipratropium bromide).
• Three acceptable tests of FEV1, FVC and PEF (of which 2 are 
repeatable) must be performed. 
• The best post-bronchodilator FEV1 and FVC are evaluated for 
improvement compared with the best pre-bronchodilator FEV1 and 
FVC. The percentage improvement in FEV1 can be calculated using 
the formula: [FEV1 post-BD - FEV1 pre-BD/FEV1 pre-BD] × 100.
• A significant bronchodilator response is present if either the 
FEV1 or FVC improve by 200 ml and 12%. Reversibility may be 
complete (when the post-bronchodilator values improve to at 
least 80% of predicted) or partial (when the post-bronchodilator 
values improve to less than 80% of predicted).
8. Interpretation and reporting of results
Observed results should always be compared with an appropriate 
reference population, and expressed as percentage observed/predicted.2-4 
Predicted values for FVC and FEV1 are calculated from equations based 
on age, height and gender, as these parameters are the major determinants 
of lung and airway size in healthy individuals.17-19 Practically all office 
spirometers are programmed with many prediction equations derived 
from the study of Europeans. The European Community for Steel and 
Coal (ECSC, Table 5) equations are the most widely used.19
Most international guidelines for spirometry and the diagnosis and 
management of chronic respiratory conditions still advocate the use 
of 80% of predicted FVC and FEV1 as suggested cut-off values,
3-5,20 
given the ease of calculation and interpretation. From a scientific 
perspective, however, the lower limit of normal (LLN) has a superior 
diagnostic accuracy.21-23 
The use of inappropriate predicted values can result in a falsely 
increased rate of abnormal results in clinically normal people. 
Evidence suggests that southern African indigenous populations, 
compared with Europeans, show similar or higher FEV1/FVC% and a 
lower FVC and FEV1 (up to 10%), but it has also been suggested that 
socio-economic variables may explain these observations.2 
In the past a correction factor of 0.9 for adjusting predicted values 
(FVC and FEV1) was sometimes applied for black patients and those 
of Asian ancestry.2 In the absence of a large, all-inclusive study of 
the South African population, most local institutions currently use 
the European Community for Steel and Coal prediction equations 
without racial correction. 
Local prediction equations are available (Table 6), but are rarely 
used, as they are not routinely included in the software packages 
of commercially available spirometers. Technically, however, these 
equations provide more accurate predicted values for screening for 
employment, compensation, surveillance and medico-legal purposes.2 
The interpreting clinician should be aware of these considerations 
and decide on the most appropriate reference equations for their 
practice, and whether racial adjustment is necessary.
8.1 Categorisation of spirometric results
The major aims of interpreting spirometry are to confirm a clinical 
diagnosis and to estimate the severity of the disease. The initial 
assessment is based on a suggested algorithm (Fig. 7) that employs three 
variables: FEV1/FVC%, FVC (% predicted) and FEV1 (% predicted). 
Pattern recognition (see below) can also aid in this assessment. Many 
still advocate an FEV1/FVC% of <70% as indicative of obstruction, 
despite the fact that such a crude approach may lead to an under-
diagnosis in young patients and an over-diagnosis in elderly patients.24 
This can be avoided by ideally using the LLN (the lower 5th percentile), 
particularly for screening purposes and in borderline cases.2 
An obstructive ventilatory defect is defined as a disproportionate 
reduction in maximal airflow from the lung, with regard to the maximal 
volume that can be displaced from the lung. Per definition, the FEV1/VC 
Fig. 6. A: Volume-time, and B: flow-volume curves, each demonstrating 3 
acceptable forced vital capacity trials; but only #2 and #3 are reproducible as 
they are almost superimposable (adapted from Van Schalkwyk et al.2).
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Table 5. European Community for Steel and Coal prediction equations (valid for ages 18 - 70 years) 
Gender Parameter Prediction equation RSD LLN
Male FVC (l) 4.30H – 0.029A – 2.49 0.84
Predicted value – (1.64 x RSD)
FEV1 (l) 5.76H – 0.026A – 4.34 1.00
FEV1/VC – 0.18A + 87.21 11.8
Female FVC (l) 3.95H – 0.025A – 2.60 0.62
FEV1 (l) 4.43H – 0.026A – 2.89 0.71
FEV1/VC – 0.19A + 89.10 10.7
RSD = residual standard deviation; LLN = lower limit of normal (lower 5th percentile); H = height standing in m; A = age in years (for ages 18 - 25, substitute age 25 in the equation).
(Adapted from Quanjer et al.19)
Table 6. Prediction equations for South African blacks
Gender Parameter Prediction equation RSD LLN
Male FVC (l) 2.9H – 0.027A – 0.54 0.75
Predicted value – (1.64 x RSD)
FEV1 (l) 4.8H – 0.024A – 3.08 0.89
Female FVC (l) 3.4H – 0.028A – 1.87 0.64
FEV1 (l) 4.5H – 0.023A – 3.04 0.67
RSD = residual standard deviation; LLN = lower limit of normal (lower 5th percentile); H = height standing in m; A = age in years (for ages 18 - 25, substitute age 25 in the equation).
(Adapted from Louw et al.7 and Mokoetle et al.10)
Fig. 7. An algorithm for the categorisation of spirometry. LLN = lower limit of normal. 
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is <LLN (lower 5th percentile).2,6 The expiratory limb of the flow-volume 
loop appears concave (Fig. 8), as flow per volume is reduced. PEF is 
reduced, as is the FEF25-75%. FVC can be normal or reduced. Obstruction 
with reduced VC is most often due to air trapping, and the slow VC 
may be preserved in such cases. Moreover, plethysmography may then 
be indicated to evaluate the residual volume (RV), total lung capacity 
(TLC) and other parameters. A bronchodilator test should be performed 
in patients with an obstructive ventilatory defect, unless the indication 
for the test was purely screening, in which case the patient should be 
referred to a specialist. 
A restrictive ventilatory defect is characterised physiologically by 
a reduction in TLC as determined by plethysmography (TLC per 
definition <lower 5th percentile), and can be inferred on spirometry 
when the FEV1/FVC% is normal or high and the FVC is reduced (Fig. 9). 
Several conditions can reduce FVC, including pulmonary pathology (e.g. 
interstitial fibrosis), chest wall and pleural disease (e.g. large effusions) and 
neuromuscular diseases. Flow is often relatively preserved in cases with 
pulmonary pathology (due to an increased elastic recoil), but decreased 
in other causes. Restrictive impairments are often over-diagnosed, chiefly 
because of poor effort and inappropriate reference values. 
Mixed obstructive-restrictive patterns are sometimes seen, as some 
diseases (e.g. bronchiectasis) may produce both, and some patients 
may have dual pathology (e.g. COPD and interstitial pulmonary 
fibrosis). Both the FEV1/VC and TLC should be <lower 5th percentile. 
It may be challenging to categorise a patient with a mixed pattern 
solely on the basis of spirometry, and to distinguish these cases from 
obstruction with reduced VC. Patients with mixed patterns should 
therefore be referred to a specialist centre for further investigations. 
Variable and fixed large airway obstruction often gives rise to 
strikingly abnormal flow-volume loops. Fixed obstruction causes 
a so-called ‘hamburger’ pattern (Fig. 10). The inspiratory limb is 
flattened (horizontal) with variable extrathoracic obstruction, whereas 
the expiratory limb is flattened with variable intrathoracic obstruction. 
8.2 Grading 
Impaired lung functions are generally graded to quantify respiratory 
impairment/disability for medico-legal purposes, and to optimise and 
standardise treatment.2 Previously, lung functions were graded according 
to the worst-affected parameter (usually FEV1 for obstructive impairment 
and FVC for restrictive impairment).2 However, the ATS/ERS guidelines 
suggest grading both obstructive and restrictive ventilatory impairments 
solely according to FEV1, as there is little or no evidence for the use 
of FVC, VC or even TLC as a parameter of impairment.6 Where 
appropriate, post-bronchodilator FEV1 values should be used (Table 7). 
Large airway obstruction should not be graded according the FEV1. 
Although spirometry is often sufficient for the evaluation of 
respiratory impairment, this is not always the case. Further investigations 
may be indicated (e.g. carbon monoxide diffusion capacity (DLCO) and/
or exercise testing), particularly in patients with clinical evidence of 
interstitial lung disease, or when a disproportionate degree of dyspnoea 
is present with a relatively preserved FEV1 and FVC.
8.3 Reporting 
Spirometry reports must contain the following: 
• subject name, and date and time of testing
• demographics (gender, age and race) and personal information 
(height and weight)
• origin of reference value (and whether or not a correction factor 
was used)
• latest calibration date
• numerical values and graphs in order to assess acceptability and 
repeatability
Fig. 8. Flow-volume curves exhibiting typical obstruction.
Fig. 9. Flow-volume curve exhibiting a typical restrictive pattern.
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• basic interpretation (e.g. ‘moderate obstructive ventilatory 
impairment with no reversibility’).
Note that spirometry is often used to confirm clinical diagnoses, and 
to grade the impairment, but should never be viewed in isolation. The 
final assessment and interpretation of spirometry requires knowledge of 
medicine and the patient’s full clinical details (e.g. to diagnose COPD), 
and may also require further special investigations (e.g. radiology, 
DLCO or plethysmography). Pulmonary function technologists and 
related personnel should therefore reserve the basic interpretation to 
the categorisation of abnormalities, and not comment on the presence 
or absence of a clinically relevant disease process. 
9. Spirometry training and 
certification
9.1 Basic skills
Operators must understand the principles of spirometry summarised 
in this statement, be able to calibrate the equipment, ensure optimal 
subject co-operation, provide acceptable and repeatable results, and 
categorise common abnormalities (taking relevant reference values 
into consideration). 
9.2 Personnel 
Pulmonary clinical technologists, general practitioners certified to 
practise occupational health, specialist physicians and pulmonologists 
are trained to perform basic spirometry. Pulmonary clinical 
technologists are competent to perform advanced lung function tests, 
which are best interpreted by qualified pulmonologists or specialist 
physicians with an interest in respiratory medicine. 
The South African Thoracic Society (SATS) recognises the 
need to train other healthcare professionals (e.g. nurses) to 
perform basic spirometry, given the paucity of trained personnel, 
but cannot endorse the indiscriminate instruction to others. For 
further information on training opportunities and certification, 
contact: The Chairman, Spirometry and Training Certification 
Committee, South African Thoracic Society, PO Box 16433, 
Vlaeberg, 8018. 
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Table 7. Severity of any spirometric abnormality based on FEV1*
Severity FEV1 (% predicted) 
Mild >70
Moderate 60 - 69
Moderately severe 50 - 59
Severe 35 - 49
Very severe <35
*Adapted from Pellegrino et al.6
Fig. 10. Example of fixed large airway obstruction.
